Study Of VGX-3400, H5N1 Avian Flu Virus Plasmid DNA With Electroporation Device In Healthy Adult Males

计划入组 30 人 · 首次发布于 2010 年 8 月 19 日

Safety Study of Avian Flu Vaccine

计划入组 45 人 · 首次发布于 2006 年 12 月 6 日

Host Genetic Susceptibility to Avian Influenza A/H5N1

计划入组 500 人 · 首次发布于 2010 年 2 月 24 日

H5N1 avian influenza vaccine

H5N1 avian influenza vaccine (PowderMed)

H5N1 vaccine (Microgen State Scientific Industrial Company)

Sernova Corp

Canada

Avion Pharmaceuticals, LLC

United States

CARGILL SLU

Spain

Salarius Pharmaceuticals Partners with Texas Biomed to Test AI-Designed Antiviral Against H5N1 Avian Flu

NIH Study: Single Dose of MEDI8852 Antibody Shows Complete Protection Against H5N1 Avian Flu in Primates

Leyden Labs Secures $70 Million to Advance Intranasal Antibody Therapies Against Respiratory Viruses